Results for CheckMate -277 Phase III Clinical Trial Presented at AACR 2018
The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer
A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression
Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
The HeraSafe 2030i BSC is designed to optimize contamination control and accelerate productivity across challenging cell culture applications
Recent discoveries by researchers at Stanford University has provided new insights into the complex mechanisms of concussion
New 2D tube with external thread from Micronic provides a simpler way to build your genomic libraries
CHANGE-MS study confirms safety of GNbAC1 and reveals positive results related to neuroprotection in Multiple Sclerosis
New experimental drugs reduce hot flushes in menopausal women by almost three-quarters in just three days
How research at the AMR Centre, UK, is accelerating the fight against antimicrobial resistance
Fluctuations in female sex hormones could play a role in the development of allergies and asthma, a major review of evidence suggests
PRIMA, miniaturized wireless photovoltaic sub-retinal implant, elicited visual perception in the first human subject with Atrophic Dry-AMD
AI 'scientist' finds that toothpaste ingredient may help fight drug-resistant malaria
Mr. Alajoki, senior scientist at the technical research center of finland VTT, discusses next generation printed sensors.
Comprehensive immune profiling & monitoring
Salk researchers identify the molecular target of J147, which is nearing clinical trials to treat Alzheimer’s disease